Previous Page  47 / 51 Next Page
Information
Show Menu
Previous Page 47 / 51 Next Page
Page Background

Immunology 2018

J u l y 0 5 - 0 7 , 2 0 1 8

V i e n n a , A u s t r i a

Page 110

Journal of Clinical Immunology and Allergy

ISSN 2471-304X

1 5

t h

I n t e r n a t i o n a l C o n f e r e n c e o n

Immunology

G

lobal prevalence of allergic diseases has been on the rise for the last 30 years. In Canada, this upward trend in allergic

diseases has resulted in over 3 million Canadians being affected by allergic asthma. Asthmatic airway inflammation

is initiated by the release of inflammatory mediators (histamine) released by granulocytic cells (mast cells and basophils).

However, immunoglobulin E (IgE) antibody is also necessary for the initiation of the allergic cascade, and IgE is produced and

released exclusively by memory B cells and plasma cells. Acute allergen exposure has also been shown to increase IgE levels

in the airways of patients diagnosed with allergic asthma; however, more studies are needed to better understand local airway

inflammation. Although regulatory B cells (Bregs) have been shown to modulate IgE-mediated inflammatory processes in allergic

asthma pathogenesis, particularly in mouse models of allergic airway disease, the levels and function of these IgE+ B cells and

Bregs remain to be elucidated in human models of asthma. Thus, the overall objective for this research was to investigate the

frequency of IgE+ B cells and Bregs in allergic asthma, and the kinetics of these cells after allergen exposure. Our research shows

that allergic asthmatics have elevated levels of IgE+ B cells in the airways, that can be further increased after allergen exposure.

Therefore, local B cell production of IgE in the lungs may be an important source of IgE for initiation of acute inflammatory

responses in allergic airways. Additionally, we showed that Bregs were lower in the blood of allergic asthmatics compared to

controls, highlighting a possible dysregulation of this regulatory cell type in allergic asthmatics, which may contribute to disease

pathology. Furthermore, after whole lung allergen challenge Bregs decreased in the bone marrow with a co-incident increase in

the blood and sputum of allergic asthmatics. This pattern reflects potential trafficking of these cells from bone marrow to the

airways after exposure to allergic stimuli. However, further functional studies are warranted. Taken together, the findings of this

research highlight the local compartmental changes in IgE+ B cells and Bregs following allergen challenge of allergic airways.

Better understanding the temporal and compartmental shifts in B cell subpopulations, particularly IgE+ B cells and Bregs, may aid

in future development of therapeutics

olivejp@mcmaster.ca

IgE+ and regulatory B cells in allergic asthmatic

subject following allergen inhalation

John-Paul Oliveria

1, 2

1

McMaster University, Canada

2

Stanford University, California, USA

Insights Allergy Asthma Bronchitis 2018, Volume: 4

DOI: 10.21767/2471-304X-C1-003